Rainer Kimmig

发表

Mach das Boot nicht dort fest, Freund

Sūryakānta Tripāṭhī, Rainer Kimmig, 2006 .

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

Tanja Fehm, Sabine Kasimir-Bauer, Rainer Kimmig, 2009, Breast Cancer Research.

Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)

Harald Grallert, Thomas Illig, André Scherag, 2010, BMC Medical Genetics.

A phase 3 trial of bevacizumab in ovarian cancer.

Jacobus Pfisterer, Jalid Sehouli, Rainer Kimmig, 2011, The New England journal of medicine.

Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survival

Mahdi Rezai, Rainer Kimmig, M. Rezai, 2016, Journal of chemotherapy.

Detection of Circulating Trophoblast Particles in Peripheral Maternal Blood in Preeclampsia Complicated Pregnancies

Sabine Kasimir-Bauer, Rainer Kimmig, R. Kimmig, 2008, Hypertension in pregnancy.

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

Tanja Fehm, Oliver Hoffmann, Sabine Kasimir-Bauer, 2012, Breast Cancer Research.

Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease

Jacobus Pfisterer, Philipp Harter, Rainer Kimmig, 2010, Annals of Surgical Oncology.

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

Sabine Kasimir-Bauer, Rainer Kimmig, R. Kimmig, 2009, Breast Cancer Research and Treatment.

Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases

Oliver Hoffmann, Rainer Callies, Bodo Levkau, 2004, Modern Pathology.